AMGN logo Amgen +
Amgen
+

Amgen (AMGN) Business News

Track Amgen in real time with a live news feed covering Amgen stock news, official press releases, company announcements, and an archive of historical Amgen news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks Investment Research

10:01 AM | Tuesday | Jun 30, 2026

news photo
Loading...

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article redirect
10:01 AM | Tuesday | Jun 30, 2026

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks Investment Research

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
6:05 AM | Tuesday | Jun 30, 2026

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

The Motley Fool

Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter.

Read full article arrow
News Thumbnail
10:01 AM | Tuesday | Jun 30, 2026

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks Investment Research

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
6:05 AM | Tuesday | Jun 30, 2026

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

The Motley Fool

Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its marketing segments in the first quarter.

Read full article arrow
News Thumbnail
9:24 AM | Monday | Jun 29, 2026

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

Benzinga

The U.S. Food and Drug Administration on Friday approved Viridian Therapeutics Inc.'s (NASDAQ:VRDN) new thyroid eye disease (TED) treatment, Lumvoa (veligrotug-vvze).

Read full article arrow
News Thumbnail
8:26 AM | Friday | Jun 26, 2026

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

WSJ

The committee is recommending that no new patients start treatment with Tavneos and that existing patients be switched to suitable alternatives.

Read full article arrow
News Thumbnail
7:10 AM | Friday | Jun 26, 2026

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

Reuters

The European Medicines Agency on ‌Friday recommended revoking the marketing authorisation for Amgen's rare autoimmune disease drug, ​Tavneos, citing a lack of ​benefits that outweigh its risks.

Read full article arrow
News Thumbnail
6:50 PM | Wednesday | Jun 24, 2026

Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know

Zacks Investment Research

In the most recent trading session, Amgen (AMGN) closed at $351.93, indicating a +1.42% shift from the previous trading day.

Read full article arrow
News Thumbnail
10:51 AM | Tuesday | Jun 23, 2026

Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?

Zacks Investment Research

AMGN's biosimilars business is driving growth, with new launches and a deep pipeline helping offset patent losses in key branded drugs.

Read full article arrow
News Thumbnail
2:45 AM | Tuesday | Jun 23, 2026

2 Underrated Weight Loss Stocks to Buy and Hold

Fool - Investing News

They look well-positioned to grab a slice of the fast-growing anti-obesity market.

Read full article arrow
News Thumbnail
10:01 AM | Friday | Jun 19, 2026

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Read full article arrow
News Thumbnail
12:30 PM | Wednesday | Jun 17, 2026

The Healthcare M&A Wave

Forbes

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.

Read full article arrow
News Thumbnail